Skip to content

Preferred Stock at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
$0
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$0
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$0
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$0
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$0
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$2.3B+475%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is MBX Biosciences, Inc.'s preferred stock?
MBX Biosciences, Inc. (MBX) reported preferred stock of $0 in Q1 2026.
What does preferred stock mean?
Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.